Richard Scolyer: Melanoma doctor's high-stakes gamble to cure his brain cancer

Over the past decade, their team’s research on immunotherapy, which uses the body’s immune system to attack cancer cells, has dramatically improved outcomes for advanced melanoma patients around the world. Half are now essentially cured, up from less than 10%.